By Dr. Neal Mauldin
Advancements in veterinary radiation therapy are transforming cancer care for animals, bringing new hope and possibilities for their wellbeing. Offering increased precision with significantly reduced side effects, patients can maintain an excellent quality of life while achieving equivalent or better outcomes compared to older treatment protocols.
As technology continues to advance, veterinary professionals must stay updated about the latest state-of-the-art equipment and techniques—this is not the radiation therapy of generations past. By remaining at the forefront of oncologic treatments, veterinarians can provide enhanced cancer care options and significantly improve the lives of pet patients and their families.
Dr. Neal Mauldin, Chief Veterinary Medical Officer at PetCure Oncology and the National Director of Radiation Oncology for Thrive Pet Healthcare, is a pioneer in the field of veterinary oncology, having supervised the treatment of over 8,000 pets with stereotactic radiation (SRS/SRT) since 2010. With triple-board certification in internal medicine, medical oncology, and radiation oncology, his over 37 years of experience include roles at VCA Canada Western, the Animal Medical Center in New York, and Louisiana State University. A former president of the Veterinary Cancer Society, his training spans Texas A&M University, the Animal Medical Center, and a fellowship at Memorial Sloan Kettering. 
